explore -WSS

explore

author：fashion 2025-09-27 16:50:18 - browse：59215

WASHINGTON — For those already felled by fumes from the Brazilian Blowout, it might be small consolation, but lawmakers are pushing ahead with a campaign for better oversight of the beauty business.

Despite its booming growth, the cosmetics industry in the US has been virtually unregulated. The Food, Drug, and Cosmetic Act, adopted in 1938, essentially allowed personal care product companies to self-police.

But rising public concern over bad reactions to makeup, hair dyes, and fragrances, as well as evidence of long-term health risks from some of their chemical contents, has led lawmakers to try to toughen the regulatory framework for the $60 billion enhancement industry.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Covid vaccines: Private market messier than government rollout

explore

WSS

WHO recommends dropping component of many flu vaccines

How one patient went off dialysis — and others can too

Senator probes 340B programs at Cleveland Clinic, Bon Secours

Headspace, Meta partner to launch VR meditation app for Quest

Covid vaccines: Private market messier than government rollout

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

entertainment

explore

hotspot

United colonoscopy coverage change 'may cost lives,' doctors say

How one patient went off dialysis — and others can too

At least 13 dead in Texas as scorching temps continue

Novo Nordisk obesity pill bests Wegovy in early trial

Heart attack and stroke risk calculators need revising

First medicine developed to treat MASH expected to be approved soon

23andMe had bad news about my health. I wish a person had delivered it

Data show record exodus of life scientists from academia

Bright Health sells Medicare Advantage business to Molina

Headspace, Meta partner to launch VR meditation app for Quest

focus

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

Sudafed saga points to U.S. issues with evaluating older drugs

The drug industry has found itself all alone in Washington

Former medical device CEO who sold dummy, plastic parts convicted of fraud

WHO recommends dropping component of many flu vaccines

Mindstrong's demise and the future of mental health care

explore

Wikipedia

explore

hotspot